Long-term effect of fingolimod on cardiovascular functioning in people with relapsing-remitting multiple sclerosis

被引：0
|
作者：
Haase, R. [1 ]
Forberger, C. [1 ]
Schilling, M. [1 ]
Piatkowski, F. [1 ]
Akgun, K. [1 ]
Rudiger, H. [1 ]
Ziemssen, T. [1 ]
机构：
[1] Univ Hosp Carl Gustav Carus Dresden, Dept Neurol, Ctr Clin Neurosci, Dresden, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2021年 / 27卷 / 2_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P726
引用
收藏
页码：609 / 610
页数：2
相关论文
共 50 条
  • [21] REAL WORLD EVIDENCE (RWE) ON LONG-TERM PERSISTENCE OF FINGOLIMOD IN RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS) IN AUSTRALIA
    Walker, Robert
    Schulz, Mark
    Arora, Birendra
    Chung, Eric
    Juneja, Prabhjot
    Verhaeghe, Stephane
    Spelman, Tim
    Broadley, Simon
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (06): : E23 - E24
  • [22] Pharmacogenomic predictors of fingolimod response in relapsing-remitting multiple sclerosis
    Campagna, M. P.
    Stankovich, J.
    Zhong, M.
    Kleinova, P.
    Matesanz, F.
    Eichau, S.
    Slee, M.
    Kilpatrick, T.
    Kubala Havrdova, E.
    Izquierdo, G.
    Patsopoulos, N.
    Lea, R.
    Lechner-Scott, J.
    Butzkueven, H.
    Jokubaitis, V.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 660 - 661
  • [23] Fingolimod: A Review of Its Use in Relapsing-Remitting Multiple Sclerosis
    Mark Sanford
    Drugs, 2014, 74 : 1411 - 1433
  • [24] Fingolimod: A Review of Its Use in Relapsing-Remitting Multiple Sclerosis
    Sanford, Mark
    DRUGS, 2014, 74 (12) : 1411 - 1433
  • [25] Predicting response to fingolimod in patients with relapsing-remitting multiple sclerosis
    Giuliani, M.
    Prosperini, L.
    Fanelli, F.
    Hirsch, M. N.
    De Angelis, F.
    Pozzilli, C.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 306 - 306
  • [26] Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis
    Christopher, Karen L.
    Elner, Victor M.
    Demirci, Hakan
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2017, 33 (03): : E73 - E75
  • [27] Glioblastoma following treatment with fingolimod for relapsing-remitting multiple sclerosis
    Sharim, Justin
    Tashjian, Randy
    Golzy, Nima
    Pouratian, Nader
    JOURNAL OF CLINICAL NEUROSCIENCE, 2016, 30 : 166 - 168
  • [28] Glatiramer acetate: long-term safety and efficacy in relapsing-remitting multiple sclerosis
    Boster, Aaron L.
    Ford, Corey C.
    Neudorfer, Orit
    Gilgun-Sherki, Yossi
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2015, 15 (06) : 575 - 586
  • [29] Interferons in relapsing-remitting multiple sclerosis -: Are there benefits from long-term use?
    Fernández, O
    CNS DRUGS, 2004, 18 (15) : 1057 - 1070
  • [30] Long-term adherence to interferon beta therapy in relapsing-remitting multiple sclerosis
    Portaccio, E
    Zipoli, V
    Siracusa, G
    Sorbi, S
    Amato, MP
    MULTIPLE SCLEROSIS, 2005, 11 : S158 - S158
12345